Amarin Corporation plc Stock Deutsche Boerse AG
Equities
EH3A
US0231112063
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.71 EUR | -3.40% | -2.74% | -4.70% |
Sales 2024 * | 202M 186M | Sales 2025 * | 215M 198M | Capitalization | 355M 328M |
---|---|---|---|---|---|
Net income 2024 * | -70M -64.55M | Net income 2025 * | -64M -59.01M | EV / Sales 2024 * | 1.54 x |
Net cash position 2024 * | 43.92M 40.5M | Net cash position 2025 * | 159M 146M | EV / Sales 2025 * | 0.92 x |
P/E ratio 2024 * |
-4.91
x | P/E ratio 2025 * |
-5.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.48% |
Latest transcript on Amarin Corporation plc
1 day | -3.40% | ||
1 week | -2.74% | ||
1 month | -12.88% | ||
3 months | -22.83% | ||
6 months | -0.70% | ||
Current year | -4.70% |
Managers | Title | Age | Since |
---|---|---|---|
Patrick Holt
CEO | Chief Executive Officer | 52 | 23-07-17 |
Thomas Reilly
DFI | Director of Finance/CFO | 52 | 22-06-19 |
Compliance Officer | 55 | Nov. 14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Louis Sterling
BRD | Director/Board Member | 45 | 23-02-27 |
Odysseas Kostas
CHM | Chairman | 49 | 23-02-27 |
Keith Horn
BRD | Director/Board Member | 66 | 23-02-27 |
Date | Price | Change |
---|---|---|
24-05-31 | 0.71 | -3.40% |
24-05-30 | 0.735 | -.--% |
24-05-29 | 0.735 | +0.68% |
24-05-28 | 0.73 | +2.10% |
24-05-27 | 0.715 | -2.05% |
Delayed Quote Deutsche Boerse AG, May 31, 2024 at 03:11 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- AMRN Stock
- EH3A Stock